Hennion & Walsh Asset Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-16,418	Closed	-$117K	–	805
2022 Q1	$117K	Sell	16,418 -826	-5%	-$8.09K	0.01%	760
2021 Q4	$228K	Sell	17,244 -1,091	-6%	-$18K	0.01%	696
2021 Q3	$422K	Sell	18,335 -907	-5%	-$27K	0.02%	544
2021 Q2	$845K	Buy	19,242 +720	+4%	+$40.1K	0.05%	399
2021 Q1	$1.34M	Buy	+18,522	New	+$1.32M	0.08%	295

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Hennion & Walsh Asset Management's ORTX Position: Q2 2022 in Review

Hennion & Walsh Asset Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2022, closing a stake of 16,418 shares — an estimated $117K sold.

Hennion & Walsh Asset Management first reported a position in ORTX in Q1 2021 and held it in 5 quarters. The position peaked at $1.34M in Q1 2021. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

Hennion & Walsh Asset Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
Hennion & Walsh Asset Management sold 16,418 Orchard Therapeutics plc American Depositary Shares shares in Q2 2022, an estimated $117K.
Hennion & Walsh Asset Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 5 quarters.
Hennion & Walsh Asset Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1.34M in Q1 2021.
50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2022, filed 19 Jul 2022.